supported by the National Natural Science Foundation of China(No.82125012,91849208);the National Key Research and Development Program of China(No.2021ZD0202400)。
supported by the Tai-Shan Scholar Program of Shandong Province (Code:ts20070743);Beijing Hospitals Authority's Ascent Plan (Code:DFL20221201).
Vulvar cancer is the fourth most common gynecological malignancy,with a global incidence of an estimated 45,240 new cases and 17,427 deaths in 2022.1 The 5-year survival rate for vulvar cancer is about 70%based on dat...
The studies involving human participants were approved by The First Affiliated Hospital of Jinan University Ethics Committee(KY-2021-095);The participants provided their written informed consent to participate in this study;Animalinvolved experimental protocols were compliance with guidelines and licenses;approved by the Laboratory Animal Center of Jinan University(20220225-65).
The dysregulation of exosomal microRNAs(miRNAs)plays a crucial role in the development and progression of cancer.This study investigated the role of a newly identified serum exosomal miRNA miR-4256 in gastric cancer(G...